Overview
Christopher Millet is a primary care provider, practicing in Internal Medicine in Monroe, New Jersey. Dr. Millet is rated as an Experienced provider by MediFind in the treatment of Muscle Atrophy. His top areas of expertise are COVID-19, Muscle Atrophy, Pulmonary Sequestration, Tissue Biopsy, and Endovascular Embolization. Dr. Millet is currently accepting new patients.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
350 Forsgate Dr, Monroe, NJ 08831
1411 Woodbourne Rd, Levittown, PA 19057
1 Plainsboro Rd, Plainsboro, NJ 08536
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Steven Heymsfield is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Heymsfield is rated as a Distinguished provider by MediFind in the treatment of Muscle Atrophy. His top areas of expertise are Obesity, Muscle Atrophy, Malnutrition, Transcobalamin Deficiency, and Gastric Bypass.
Point Pleasant Medical Group LLC
Sanjay Kumar is a primary care provider, practicing in Internal Medicine in Point Pleasant Boro, New Jersey. Dr. Kumar is rated as a Distinguished provider by MediFind in the treatment of Muscle Atrophy. His top areas of expertise are Pneumonia, Muscle Atrophy, Acute Kidney Failure, Gastrostomy, and Endoscopy. Dr. Kumar is currently accepting new patients.
John Dellosso is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Dellosso is rated as an Advanced provider by MediFind in the treatment of Muscle Atrophy. His top areas of expertise are Muscle Atrophy, Saddle Pulmonary Embolism, Myelitis, and AIDS Dysmorphic Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Dr. Millet isAdvanced. Learn about COVID-19.
- Experienced
- AscitesDr. Millet isExperienced. Learn about Ascites.
- Bronchiolitis ObliteransDr. Millet isExperienced. Learn about Bronchiolitis Obliterans.
- Endovascular EmbolizationDr. Millet isExperienced. Learn about Endovascular Embolization.
- Enlarged LiverDr. Millet isExperienced. Learn about Enlarged Liver.
- FaintingDr. Millet isExperienced. Learn about Fainting.
- Familial HypertriglyceridemiaDr. Millet isExperienced. Learn about Familial Hypertriglyceridemia.